SCM
IBIO icon

Silverarc Capital Management’s iBio IBIO Stock Holding History

Silverarc Capital Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429K Buy
226,000
+120,000
+113% +$278K 0.04% 70
2025
Q4 		$205K Buy
+106,000
New +$145K 0.03% 67

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Silverarc Capital Management's IBIO Position: Q1 2026 in Review

Silverarc Capital Management increased its iBio (IBIO) stake by 113% in Q1 2026, buying an estimated $278K and bringing the position to 226,000 shares worth $429K. The position accounts for 0.04% of the portfolio, ranked #70.

Silverarc Capital Management first reported a position in IBIO in Q4 2025 and has held it in 2 quarters since. 52 funds tracked by Wall St. Rank hold IBIO as of Q1 2026.

  • Silverarc Capital Management held 226,000 shares of iBio worth $429K as of Q1 2026.
  • Silverarc Capital Management bought 120,000 iBio shares in Q1 2026, an estimated $278K.
  • iBio made up 0.04% of Silverarc Capital Management's portfolio in Q1 2026, its #70 holding.
  • Silverarc Capital Management first reported a position in iBio in Q4 2025 and has held it in 2 quarters since.
  • 52 funds tracked by Wall St. Rank held iBio as of Q1 2026.

Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.